Considering the differences between IL-27rα−/−Roquinsan/san mice, pristane-treated IL-27rα−/− mice, and IL-27rα−/− MRL/lpr mice, several aspects may correlate with different results of lupus development, such as different mouse models and differences in the experimental setup. Here, IL27RA is linked to systemic lupus erythematosus.